630 related articles for article (PubMed ID: 32564421)
21. Tetramethylpyrazine reduces glucose and insulin-induced activation of hepatic stellate cells by inhibiting insulin receptor-mediated PI3K/AKT and ERK pathways.
Zhang F; Zhang Z; Kong D; Zhang X; Chen L; Zhu X; Lu Y; Zheng S
Mol Cell Endocrinol; 2014 Jan; 382(1):197-204. PubMed ID: 24071517
[TBL] [Abstract][Full Text] [Related]
22. The Phenylethanol Glycoside Liposome Inhibits PDGF-Induced HSC Activation via Regulation of the FAK/PI3K/Akt Signaling Pathway.
Zhang SL; Ma L; Zhao J; You SP; Ma XT; Ye XY; Liu T
Molecules; 2019 Sep; 24(18):. PubMed ID: 31505837
[No Abstract] [Full Text] [Related]
23. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces hepatic stellate cell (HSC) activation and liver fibrosis in C57BL6 mouse via activating Akt and NF-κB signaling pathways.
Han M; Liu X; Liu S; Su G; Fan X; Chen J; Yuan Q; Xu G
Toxicol Lett; 2017 May; 273():10-19. PubMed ID: 28302560
[TBL] [Abstract][Full Text] [Related]
24. [Quercetin induces hepatic stellate cell apoptosis by inhibiting the PI3K/Akt signaling pathway
Gao X; Zhao X; Zhang C; Yan Y; Jin R; Ma Y
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1725-1733. PubMed ID: 37933648
[TBL] [Abstract][Full Text] [Related]
25. Doxazosin Attenuates Liver Fibrosis by Inhibiting Autophagy in Hepatic Stellate Cells via Activation of the PI3K/Akt/mTOR Signaling Pathway.
Xiu AY; Ding Q; Li Z; Zhang CQ
Drug Des Devel Ther; 2021; 15():3643-3659. PubMed ID: 34456560
[TBL] [Abstract][Full Text] [Related]
26. The synergistic anti-proliferative effect of the combination of diosmin and BEZ-235 (dactolisib) on the HCT-116 colorectal cancer cell line occurs through inhibition of the PI3K/Akt/mTOR/NF-κB axis.
Helmy MW; Ghoneim AI; Katary MA; Elmahdy RK
Mol Biol Rep; 2020 Mar; 47(3):2217-2230. PubMed ID: 32088816
[TBL] [Abstract][Full Text] [Related]
27. Protective effect of Idelalisib on carbon tetrachloride-induced liver fibrosis via microRNA-124-3P/phosphatidylinositol-3-hydroxykinase signalling pathway.
Li X; Li H; Zhang S; Zhang R; Li J; Wei Y; Yang C; Zhang F; Zhou H
J Cell Mol Med; 2021 Dec; 25(24):11185-11197. PubMed ID: 34747105
[TBL] [Abstract][Full Text] [Related]
28. Catalpol synergistically potentiates the anti-tumour effects of regorafenib against hepatocellular carcinoma via dual inhibition of PI3K/Akt/mTOR/NF-κB and VEGF/VEGFR2 signaling pathways.
El-Hanboshy SM; Helmy MW; Abd-Alhaseeb MM
Mol Biol Rep; 2021 Nov; 48(11):7233-7242. PubMed ID: 34596810
[TBL] [Abstract][Full Text] [Related]
29. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
30. Cucurbitacin E ameliorates hepatic fibrosis in vivo and in vitro through activation of AMPK and blocking mTOR-dependent signaling pathway.
Wu YL; Zhang YJ; Yao YL; Li ZM; Han X; Lian LH; Zhao YQ; Nan JX
Toxicol Lett; 2016 Sep; 258():147-158. PubMed ID: 27363783
[TBL] [Abstract][Full Text] [Related]
31. Perindopril Ameliorates Hepatic Ischemia Reperfusion Injury Via Regulation of NF-κB-p65/TLR-4, JAK1/STAT-3, Nrf-2, and PI3K/Akt/mTOR Signaling Pathways.
Kamel EO; Hassanein EHM; Ahmed MA; Ali FEM
Anat Rec (Hoboken); 2020 Jul; 303(7):1935-1949. PubMed ID: 31606943
[TBL] [Abstract][Full Text] [Related]
32. Ginsenoside Rh2 impedes proliferation and migration and induces apoptosis by regulating NF-κB, MAPK, and PI3K/Akt/mTOR signaling pathways in osteosarcoma cells.
Li C; Gao H; Feng X; Bi C; Zhang J; Yin J
J Biochem Mol Toxicol; 2020 Dec; 34(12):e22597. PubMed ID: 32762018
[TBL] [Abstract][Full Text] [Related]
33. Antifibrotic effects of tanshinol in experimental hepatic fibrosis by targeting PI3K/AKT/mTOR/p70S6K1 signaling pathways.
Peng R; Wang S; Wang R; Wang Y; Wu Y; Yuan Y
Discov Med; 2017 Feb; 23(125):81-94. PubMed ID: 28371611
[TBL] [Abstract][Full Text] [Related]
34. CD73 aggravates alcohol-related liver fibrosis by promoting autophagy mediated activation of hepatic stellate cells through AMPK/AKT/mTOR signaling pathway.
Wu X; Liu XQ; Liu ZN; Xia GQ; Zhu H; Zhang MD; Wu BM; Lv XW
Int Immunopharmacol; 2022 Dec; 113(Pt A):109229. PubMed ID: 36330907
[TBL] [Abstract][Full Text] [Related]
35. VS-5584 as a PI3K/mTOR inhibitor enhances apoptotic effects of subtoxic dose arsenic trioxide via inhibition of NF-κB activity in B cell precursor-acute lymphoblastic leukemia.
Toosi B; Zaker F; Alikarami F; Kazemi A; Teremmahi Ardestanii M
Biomed Pharmacother; 2018 Jun; 102():428-437. PubMed ID: 29574283
[TBL] [Abstract][Full Text] [Related]
36. Ligustrazin increases lung cell autophagy and ameliorates paraquat-induced pulmonary fibrosis by inhibiting PI3K/Akt/mTOR and hedgehog signalling via increasing miR-193a expression.
Liu MW; Su MX; Tang DY; Hao L; Xun XH; Huang YQ
BMC Pulm Med; 2019 Feb; 19(1):35. PubMed ID: 30744607
[TBL] [Abstract][Full Text] [Related]
37. HJC0416 Attenuates Fibrogenesis in Activated Hepatic Stellate Cells via STAT3 and NF-κB Pathways.
Sommerhalder C; Cummins CB; Wang X; Ramdas D; Lopez ON; Gu Y; Zhou J; Radhakrishnan RS
J Surg Res; 2021 May; 261():334-342. PubMed ID: 33486415
[TBL] [Abstract][Full Text] [Related]
38. ROS-dependent inhibition of the PI3K/Akt/mTOR signaling is required for Oroxylin A to exert anti-inflammatory activity in liver fibrosis.
Shen M; Guo M; Wang Z; Li Y; Kong D; Shao J; Tan S; Chen A; Zhang F; Zhang Z; Zheng S
Int Immunopharmacol; 2020 Aug; 85():106637. PubMed ID: 32512269
[TBL] [Abstract][Full Text] [Related]
39. The Therapeutic Mechanisms of Propolis Against CCl
Badr G; Sayed EA; Waly H; Hassan KA; Mahmoud MH; Selamoglu Z
Cell Physiol Biochem; 2019; 53(2):301-322. PubMed ID: 31343125
[TBL] [Abstract][Full Text] [Related]
40. Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.
Cai CX; Buddha H; Castelino-Prabhu S; Zhang Z; Britton RS; Bacon BR; Neuschwander-Tetri BA
Dig Dis Sci; 2017 Apr; 62(4):968-978. PubMed ID: 28194671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
